121 related articles for article (PubMed ID: 25313768)
1. Primary peripheral neurolymphomatosis mimicking synovial sarcoma: FDG PETCT to the rescue.
Padma S; Sundaram PS; Praveen Kumar SL
J Cancer Res Ther; 2014; 10(3):726-9. PubMed ID: 25313768
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R
J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845
[TBL] [Abstract][Full Text] [Related]
3. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M
Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
[TBL] [Abstract][Full Text] [Related]
4. A rare case of primary pulmonary synovial sarcoma in a pediatric patient evaluated by (18)F-FDG PET/CT.
Treglia G; Caldarella C; Taralli S
Clin Nucl Med; 2014 Feb; 39(2):e166-8. PubMed ID: 24536091
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS
Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
[TBL] [Abstract][Full Text] [Related]
6. Neurolymphomatosis: MRI and (18) FDG-PET features.
Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
[TBL] [Abstract][Full Text] [Related]
7. Primary synovial sarcoma of the kidney: use of PET/CT in diagnosis and follow-up.
Erturhan S; Seçkiner I; Zincirkeser S; Erbagci A; Celik M; Yagci F; Karakok M
Ann Nucl Med; 2008 Apr; 22(3):225-9. PubMed ID: 18498039
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
[TBL] [Abstract][Full Text] [Related]
9. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
[TBL] [Abstract][Full Text] [Related]
10. F-18 FDG PET/CT in primary tonsillar lymphoma.
Zhang MJ; Jiang JJ; Jiang MS; He W
Clin Nucl Med; 2010 Sep; 35(9):710-2. PubMed ID: 20706049
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT findings in rare sarcomas.
Ergül N; Aydın M
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):324-7. PubMed ID: 23352751
[TBL] [Abstract][Full Text] [Related]
12. An unusual case of retroperitoneal synovial sarcoma with CT, MRI, and F-18 FDG PET/CT findings.
Tabar M; Gultekin MA; Peker AA; Toprak H
J Clin Ultrasound; 2024 Jan; 52(1):89-91. PubMed ID: 37947310
[TBL] [Abstract][Full Text] [Related]
13. Lymph node uptake of 18F-fluorodeoxyglucose detected with positron emission tomography/computed tomography mimicking malignant lymphoma in a patient with Kikuchi disease.
Zhang MJ; Xiao L; Zhu YH; Jiang JJ; Jiang MS; He W
Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):477-9. PubMed ID: 21156466
[TBL] [Abstract][Full Text] [Related]
14. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
[TBL] [Abstract][Full Text] [Related]
15. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.
Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):645-50. PubMed ID: 24252024
[TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG PET/CT in primary right eyelid lymphoma.
Wang WH; Zhan FH; Li YJ; Dang CJ
Clin Nucl Med; 2013 Apr; 38(4):280-2. PubMed ID: 23455533
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT differentiating two malignant tumors in the same patient.
Shai A; Leitzin L; Steiner M; Peer A; Srour S; Shalom RB
Acta Oncol; 2012 Jan; 51(1):142-4. PubMed ID: 21851187
[No Abstract] [Full Text] [Related]
19. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
20. Neurolymphomatosis detected by (18)F-FDG PET/CT scan - a case report.
Czepczyński R; Guzikowska-Ruszkowska I; Sowiński J
Nucl Med Rev Cent East Eur; 2008; 11(2):73-5. PubMed ID: 19585459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
